Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4599093 | 1.00 | NFKB1 (0.34) | NFKB1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL5053530 | 1.00 | NFKB1 (0.34) | NFKB1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL9700814 | 0.82 | KDM4E (0.34) | NFKB1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL3990273 | 0.79 | — | — | |
| SCHEMBL4039881 | 0.79 | — | — | |
| SCHEMBL3990272 | 0.79 | — | — | |
| SCHEMBL514472 | 0.77 | — | — | |
| SCHEMBL514471 | 0.77 | — | — | |
| SCHEMBL1006670 | 0.76 | ALDH1A1 (0.50) | NFKB1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL1006669 | 0.76 | ALDH1A1 (0.50) | NFKB1KDM4EMAPTTHRBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3034512-B1 | A process for producing iron (III) casein N-acetyl-aspartylated complexes and use thereof in pharmaceutical compositions | TSETI IOULIA (GR) | 2017-12-06 | — | — | EP | claimed |
| WO-2019190266-A1 | PSMA-TARGETED RADIOPHARMACEUTICAL FOR DIAGNOSING AND TREATING PROSTATE CANCER | (주)퓨쳐켐 | 2019-10-03 | — | — | WO | disclosed |
| WO-2016096203-A1 | A PROCESS FOR PRODUCING IRON (III) CASEIN N-ACETYL-ASPARTYLATED COMPLEXES AND USE THEREOF IN PHARMACEUTICAL COMPOSITIONS | TSETI IOULIA (GR) | 2016-06-23 | — | — | WO | disclosed |
| EP-1910309-A2 | CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR ß-SECRETASE MODULATION | Wyeth (US) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007016012-A2 | CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION | WYETH (US) | 2007-02-08 | — | — | WO | disclosed |
| US-20070027199-A1 | Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation | WYETH (US) | 2007-02-01 | — | — | US | disclosed |
| US-4593045-A | N-acetyl-L-aspartyl taurine useful as hypertensive agent | Societe a Responsabilite Limite dite: B.F.B. Estudes et Recherches Experimentales (FR) | 1986-06-03 | — | — | US | disclosed |
| EP-0069674-B1 | MEDICINES CONTAINING AN N-ACYL-L-ASPACTYL-TAURINE | SOCIETE BFB (FR) | 1985-04-17 | — | — | EP | disclosed |
| EP-0069674-A1 | Medicines containing an N-acyl-L-aspactyl-taurine | SOCIETE BFB (FR) | 1983-01-12 | — | — | EP | disclosed |
| US-4175084-A | AND AN N-ACYL ASPARTIC ACID CARRIER, FOR PSYCHOLOGICAL DISORDERS, LEARNING ENHANCEMENT AND SLEEP INDUCTION | SENTRALINSTITUTT FOR INDUSTRIELL FORSKNING (NO) | 1979-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070027199-A1 | Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation | BACE1, BACE2, APP | NFKB1 1135/4885KDM4E 1003/4885MAPT 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.